Literature DB >> 20678014

The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings.

Sahil Khanna1, Darrell S Pardi.   

Abstract

Clostridium difficile infection (CDI) is a leading cause of nosocomial infections, with disease severity ranging from mild diarrhea to fulminant colitis. The incidence and severity of CDI has been on the rise over the last 10-20 years, with CDI being increasingly described outside healthcare settings and in populations previously thought to be at low risk. There has also been an increase in the morbidity, mortality and economic burden associated with CDI in the last several years. This increasing incidence and severity is thought to be at least partially due to frequent antibiotic use and the emergence of a hypervirulent C. difficile strain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20678014     DOI: 10.1586/egh.10.48

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  67 in total

1.  IBD: Poor outcomes after Clostridium difficile infection in IBD.

Authors:  Sahil Khanna; Darrell S Pardi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-01       Impact factor: 46.802

2.  Impact of a clinical decision support system on antibiotic prescribing for acute respiratory infections in primary care: quasi-experimental trial.

Authors:  Arch G Mainous; Carol A Lambourne; Paul J Nietert
Journal:  J Am Med Inform Assoc       Date:  2012-07-03       Impact factor: 4.497

3.  Epidemiology, outcomes, and predictors of mortality in hospitalized adults with Clostridium difficile infection.

Authors:  Sahil Khanna; Arjun Gupta; Larry M Baddour; Darrell S Pardi
Journal:  Intern Emerg Med       Date:  2015-12-22       Impact factor: 3.397

Review 4.  Stool transplants: ready for prime time?

Authors:  Jeffrey S Weissman; Walter Coyle
Journal:  Curr Gastroenterol Rep       Date:  2012-08

5.  Are there reasons to prefer tetracyclines to macrolides in older patients with community-acquired pneumonia?

Authors:  S Di Bella; F Taglietti; N Petrosillo
Journal:  Antimicrob Agents Chemother       Date:  2013-08       Impact factor: 5.191

6.  Ipilimumab-associated colitis or refractory Clostridium difficile infection?

Authors:  Arjun Gupta; Sahil Khanna
Journal:  BMJ Case Rep       Date:  2015-07-07

Review 7.  Clostridium difficile infection: management strategies for a difficult disease.

Authors:  Sahil Khanna; Darrell S Pardi
Journal:  Therap Adv Gastroenterol       Date:  2014-03       Impact factor: 4.409

Review 8.  Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance.

Authors:  Kathleen Mullane
Journal:  Ther Adv Chronic Dis       Date:  2014-03       Impact factor: 5.091

9.  Clostridioides difficile uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrhea.

Authors:  Eric J Battaglioli; Vanessa L Hale; Jun Chen; Patricio Jeraldo; Coral Ruiz-Mojica; Bradley A Schmidt; Vayu M Rekdal; Lisa M Till; Lutfi Huq; Samuel A Smits; William J Moor; Yava Jones-Hall; Thomas Smyrk; Sahil Khanna; Darrell S Pardi; Madhusudan Grover; Robin Patel; Nicholas Chia; Heidi Nelson; Justin L Sonnenburg; Gianrico Farrugia; Purna C Kashyap
Journal:  Sci Transl Med       Date:  2018-10-24       Impact factor: 17.956

10.  Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children.

Authors:  Julia Shaklee Sammons; Russell Localio; Rui Xiao; Susan E Coffin; Theoklis Zaoutis
Journal:  Clin Infect Dis       Date:  2013-03-26       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.